Edwards Lifesciences
EW
$86.43
Share price
-1.80%
Change (1 day)
-1.53%
Change (1 year)
Categories
Operating Margin for Edwards Lifesciences (EW)
Operating Margin as of April 2024 (TTM): 31.50%
According to Edwards Lifesciences's latest financial reports and stock price the company's current Operating Margin is 31.50%. At the end of 2022 the company had an Operating Margin of 32.84%.
Operating Margin history for Edwards Lifesciences from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 32.84% | 0.95% |
| 2021 | 32.53% | 55.64% |
| 2020 | 20.90% | -22.1% |
| 2019 | 26.83% | 31.18% |
| 2018 | 20.45% | -32.11% |
| 2017 | 30.13% | 21% |
| 2016 | 24.90% | -0.24% |
| 2015 | 24.96% | -49.32% |
| 2014 | 49.25% | 95.49% |
| 2013 | 25.19% | 22.36% |
| 2012 | 20.59% | 21.86% |
| 2011 | 16.90% | -8.85% |
| 2010 | 18.53% | -19.54% |
| 2009 | 23.04% | 73.43% |
| 2008 | 13.28% | -3.25% |
| 2007 | 13.73% | -17.37% |
| 2006 | 16.62% | 42.08% |
| 2005 | 11.69% | 261.91% |
| 2004 | 3.23% | -70.04% |
| 2003 | 10.78% | 35.58% |
| 2002 | 7.95% | -711.62% |
| 2001 | -1.30% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 17.17% | -45.49% | 🇮🇪 Ireland |
 Boston Scientific BSX | 11.27% | -64.22% | 🇺🇸 USA |
 Merit Medical MMSI | 7.17% | -77.24% | 🇺🇸 USA |
 LeMaitre Vascular LMAT | 16.26% | -48.38% | 🇺🇸 USA |
 ICU Medical
ICUI | -5.01% | -115.90% | 🇺🇸 USA |
 CryoLife CRY | 0.69% | -97.81% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.